A detailed history of Lindbrook Capital, LLC transactions in Taro Pharmaceutical Industries LTD stock. As of the latest transaction made, Lindbrook Capital, LLC holds 142 shares of TARO stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
142
Previous 142 -0.0%
Holding current value
$0
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$32.77 - $42.31 $3,408 - $4,400
104 Added 273.68%
142 $5,000
Q2 2023

Jul 28, 2023

SELL
$24.24 - $40.97 $1,817 - $3,072
-75 Reduced 66.37%
38 $1,000
Q1 2023

Apr 26, 2023

SELL
$23.0 - $31.59 $2,990 - $4,106
-130 Reduced 53.5%
113 $2,000
Q4 2022

Jan 24, 2023

BUY
$27.6 - $32.99 $1,711 - $2,045
62 Added 34.25%
243 $0
Q3 2022

Nov 10, 2022

BUY
$28.74 - $39.9 $3,362 - $4,668
117 Added 182.81%
181 $5,000
Q2 2022

Aug 01, 2022

BUY
$35.0 - $43.59 $700 - $871
20 Added 45.45%
64 $2,000
Q1 2022

Apr 21, 2022

SELL
$43.12 - $50.3 $19,921 - $23,238
-462 Reduced 91.3%
44 $2,000
Q4 2021

Jan 18, 2022

SELL
$47.6 - $65.0 $5,807 - $7,930
-122 Reduced 19.43%
506 $25,000
Q3 2021

Nov 05, 2021

SELL
$62.34 - $73.38 $1,246 - $1,467
-20 Reduced 3.09%
628 $40,000
Q2 2021

Jul 27, 2021

BUY
$70.26 - $76.64 $351 - $383
5 Added 0.78%
648 $47,000
Q4 2020

Jan 27, 2021

BUY
$54.4 - $73.42 $28,396 - $38,325
522 Added 431.4%
643 $47,000
Q3 2020

Nov 03, 2020

SELL
$54.41 - $68.2 $2,339 - $2,932
-43 Reduced 26.22%
121 $7,000
Q2 2020

Jul 27, 2020

SELL
$61.66 - $70.16 $8,940 - $10,173
-145 Reduced 46.93%
164 $11,000
Q1 2020

Apr 22, 2020

BUY
$59.35 - $88.73 $17,152 - $25,642
289 Added 1445.0%
309 $19,000
Q3 2019

Oct 31, 2019

BUY
$75.36 - $86.57 $1,507 - $1,731
20 New
20 $2,000
Q1 2019

Apr 23, 2019

SELL
$85.97 - $108.09 $0 - $0
0 Closed
0 $0
Q4 2018

Feb 07, 2019

BUY
$78.25 - $107.92 $0 - $0
0 New
0 $0

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.